[Federal Register Volume 82, Number 174 (Monday, September 11, 2017)]
[Notices]
[Page 42706]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19186]
=======================================================================
-----------------------------------------------------------------------
EXECUTIVE OFFICE OF THE PRESIDENT
Office of National Drug Control Policy
Notification of a Public Meeting of the President's Commission on
Combating Drug Addiction and the Opioid Crisis (Commission)
AGENCY: Office of National Drug Control Policy (ONDCP), Executive
Office of the President.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: ONDCP announces the third meeting of the President's
Commission on Combating Drug Addiction and the Opioid Crisis to advance
the Commission's work on drug issues and the opioid crisis per
Executive Order 13784. The meeting will consist of statements to the
Commission from invited government, nonprofit, and business
organizations regarding Innovative Pain Management and Prevention
Measures for Diversion followed by discussion of the issues raised.
DATES: The Commission meeting will be held on Wednesday September 27,
2017 from 12:30 p.m. until approximately 2:30 p.m. (Eastern Time).
ADDRESSES: The meeting will be held at the Eisenhower Executive Office
Building, Room 350, in the Executive Office of the President in
Washington, DC. It will be open to the public through livestreaming on
https://www.whitehouse.gov/live.
FOR FURTHER INFORMATION CONTACT: General information concerning the
Commission and its meetings can be found on ONDCP's Web site at https://www.whitehouse.gov/ondcp/presidents-commission. Any member of the
public who wishes to obtain information about the Commission or its
meetings that is not already on ONDCP's Web site or who wishes to
submit written comments for the Commission's consideration may contact
Michael Passante, Designated Federal Officer (DFO) via email at
[email protected] or telephone at (202) 395-6709. Please note
that ONDCP may post such written comments publicly on our Web site,
including names and contact information that are submitted. There will
not be oral comments from the public at the meeting. Requests to
accommodate disabilities with respect to livestreaming or otherwise
should also be sent to that email address, preferably at least 10 days
prior to the meeting to allow time for processing.
SUPPLEMENTARY INFORMATION: The Commission was established in accordance
with E.O. 13784 of March 29, 2017, the Commission's charter, and the
provisions of the Federal Advisory Committee Act (FACA), as amended, 5
U.S.C. App. 2, to obtain advice and recommendations for the President
regarding drug issues. The Executive Order, charter, and information on
the Members of the Commission are available on ONDCP's Web site. The
Commission will function solely as an advisory body and will make
recommendations regarding policies and practices for combating drug
addiction with particular focus on the current opioid crisis in the
United States. The Commission's final report is due October 1, 2017
unless there is an extension. Per E.O. 13784, the Commission shall:
a. Identify and describe the existing Federal funding used to
combat drug addiction and the opioid crisis;
b. assess the availability and accessibility of drug addiction
treatment services and overdose reversal throughout the country and
identify areas that are underserved;
c. identify and report on best practices for addiction prevention,
including healthcare provider education and evaluation of prescription
practices, collaboration between State and Federal officials, and the
use and effectiveness of State prescription drug monitoring programs;
d. review the literature evaluating the effectiveness of
educational messages for youth and adults with respect to prescription
and illicit opioids;
e. identify and evaluate existing Federal programs to prevent and
treat drug addiction for their scope and effectiveness, and make
recommendations for improving these programs; and
f. make recommendations to the President for improving the Federal
response to drug addiction and the opioid crisis.
Dated: September 6, 2017.
Michael Passante,
Deputy General Counsel, Designated Federal Officer.
[FR Doc. 2017-19186 Filed 9-8-17; 8:45 am]
BILLING CODE 3280-F5-P